Osterweis Capital Management Inc Centessa Pharmaceuticals PLC Transaction History
Osterweis Capital Management Inc
- $1.48 Billion
- Q1 2025
A detailed history of Osterweis Capital Management Inc transactions in Centessa Pharmaceuticals PLC stock. As of the latest transaction made, Osterweis Capital Management Inc holds 3,276 shares of CNTA stock, worth $44,455. This represents 0.0% of its overall portfolio holdings.
Number of Shares
3,276Holding current value
$44,455% of portfolio
0.0%Shares
1 transactions
Others Institutions Holding CNTA
# of Institutions
131Shares Held
120MCall Options Held
104KPut Options Held
294K-
Medicxi Ventures Management (Jersey) LTD20MShares$271 Million75.25% of portfolio
-
Index Venture Life Associates Vi LTD St. Helier, Y99.96MShares$135 Million100.0% of portfolio
-
General Atlantic LLC New York, NY9.68MShares$131 Million4.7% of portfolio
-
Adage Capital Partners Gp, L.L.C. Boston, MA6.95MShares$94.4 Million0.19% of portfolio
-
Perceptive Advisors LLC New York, NY6.35MShares$86.2 Million3.55% of portfolio
About Centessa Pharmaceuticals plc
- Ticker CNTA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 94,339,296
- Market Cap $1.28B
- Description
- Centessa Pharmaceuticals plc, a clinical-stage pharmaceutical company, discovers, develops, and delivers medicines to patients. Its registrational pipeline products include Lixivaptan, a vasopressin V2 receptor small molecule inhibitor that is in Phase III clinical development for the treatment of autosomal dominant polycystic kidney disease; an...